CLINICAL ASPECTS OF CANCER-ASSOCIATED THROMBOSIS
Journal
International Journal of Recent Research in Arts and Sciences
Date Issued
2023
Author(s)
Abstract
Active cancer accounts for 20% of the total incidence of venous thrombembolism (VTE), a condition called cancer-associated thrombosis (CAT) . Cancer is the leading cause of death in patients with VTE and vice versa. Risk factors for VTE can be classified into three groups: patient-related, cancer-related, and treatment-related. This review contains the most relevant, up to date, randomized controlled studies for carcinoma-associated thrombosis, pathogenesis and risk factors for CAT, risk assessment models, and most importantly, recommendation for thromboprophylaxis of patients with carcinoma, treatment of patients with CAT for both, hospitalized and outpatients, and secondary prevention of VTE, comparing efficacy and safety of low-molecular weight heparin (LMWH) to direct oral anticoagulans (DOAC), balancing between the risk of recurrent VTE and major bleeding.
File(s)![Thumbnail Image]()
Loading...
Name
IJRRAS_vol.16_2023.pdf
Size
4.41 MB
Format
Adobe PDF
Checksum
(MD5):097f8dacee148048e7ec2376b501bf59